BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 12359668)

  • 1. Interventions to improve medication adherence in schizophrenia.
    Zygmunt A; Olfson M; Boyer CA; Mechanic D
    Am J Psychiatry; 2002 Oct; 159(10):1653-64. PubMed ID: 12359668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia.
    Kopelowicz A; Zarate R; Wallace CJ; Liberman RP; Lopez SR; Mintz J
    Arch Gen Psychiatry; 2012 Mar; 69(3):265-73. PubMed ID: 22393219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia--a review of the past decade.
    Barkhof E; Meijer CJ; de Sonneville LM; Linszen DH; de Haan L
    Eur Psychiatry; 2012 Jan; 27(1):9-18. PubMed ID: 21561742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
    Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
    Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions to improve antipsychotic medication adherence: review of recent literature.
    Dolder CR; Lacro JP; Leckband S; Jeste DV
    J Clin Psychopharmacol; 2003 Aug; 23(4):389-99. PubMed ID: 12920416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP
    J Psychiatr Pract; 2010 Sep; 16(5):306-24. PubMed ID: 20859108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of interventions to improve compliance with antipsychotic medication in people suffering from schizophrenia-results of recent reviews].
    Puschner B; Born A; Giessler A; Helm H; Becker T; Angermeyer MC
    Psychiatr Prax; 2005 Mar; 32(2):62-7. PubMed ID: 15712037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled multimodal behavioral intervention trial for improving antiepileptic drug adherence.
    Pakpour AH; Gholami M; Esmaeili R; Naghibi SA; Updegraff JA; Molloy GJ; Dombrowski SU
    Epilepsy Behav; 2015 Nov; 52(Pt A):133-42. PubMed ID: 26414343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.
    Lacro JP; Dunn LB; Dolder CR; Leckband SG; Jeste DV
    J Clin Psychiatry; 2002 Oct; 63(10):892-909. PubMed ID: 12416599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive psychosocial therapies for the treatment of schizophrenia.
    Patterson TL; Leeuwenkamp OR
    Schizophr Res; 2008 Mar; 100(1-3):108-19. PubMed ID: 18226500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing medication adherence in patients with bipolar disorder.
    Berk L; Hallam KT; Colom F; Vieta E; Hasty M; Macneil C; Berk M
    Hum Psychopharmacol; 2010 Jan; 25(1):1-16. PubMed ID: 20041478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving adherence to antipsychotic pharmacotherapy.
    Masand PS; Narasimhan M
    Curr Clin Pharmacol; 2006 Jan; 1(1):47-56. PubMed ID: 18666377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence in patients with schizophrenia.
    Phan SV
    Int J Psychiatry Med; 2016; 51(2):211-9. PubMed ID: 27079779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial.
    Chien WT; Mui J; Gray R; Cheung E
    BMC Psychiatry; 2016 Feb; 16():42. PubMed ID: 26911397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on psychoeducation enhancing results of adherence in patients with schizophrenia (SPERA-S): study protocol for a randomized controlled trial.
    Petretto DR; Preti A; Zuddas C; Veltro F; Rocchi MB; Sisti D; Martinelli V; Carta MG; Masala C;
    Trials; 2013 Oct; 14():323. PubMed ID: 24099414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project Study.
    Pitschel-Walz G; Bäuml J; Bender W; Engel RR; Wagner M; Kissling W
    J Clin Psychiatry; 2006 Mar; 67(3):443-52. PubMed ID: 16649832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.